Lilly says deeply concerned by bribery allegations in China

Administrator 0 Reuters Health
Print Email

SHANGHAI (Reuters) - U.S. drugmaker Eli Lilly and Co said it was "deeply concerned" about allegations published in a Chinese newspaper that it spent more than 30 million yuan ($4.90 million) to bribe doctors in China to prescribe the firm's medicines instead of rival products.


Read Full Article


You can contact us at: